Physician profile
Robert L Williams
NPI 1922059971
$600.87
in general payments reported to CMS, 2019-2025
9 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.90 · 2021: $211 · 2022: $171 · 2023: $17.59 · 2024: $15.69 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $280.16 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $137.67 | 2020-2025 | General - Pain Management |
| Viiv Healthcare Company | $64.47 | 2025 | |
| Glaxosmithkline, LLC. | $35.38 | 2025 | Benlysta, Arexvy, Shingrix |
| Actelion Pharmaceuticals US, INC. | $21.43 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.12 | 2025 | Austedo Xr |
| Aspira Women'S Health INC | $15.69 | 2024 | Ova1 |
| Hologic Sales and Service, LLC | $15.53 | 2022 | |
| Novo Nordisk INC | $14.42 | 2025 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.